Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease

Clinical trial NCT07741045 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07741045
Sponsor: Hangzhou PhecdaMed Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease (PD)Parkinson Disease 6, Early-Onset

Start date: 2026-08-03
Primary completion: 2028-01-15
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.